Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.

Bladder cancer is the ninth most common cancer worldwide, and the number of diagnosed incident cases is set to increase.

A recent study reveals that extended lymphadenectomy offers no survival advantage over standard lymphadenectomy for patients ...

This study included a review of consecutive patients diagnosed with NMIBC between January 2005 and May 2023 to identify ...

Eligible patients had T2-T4a muscle-invasive bladder cancer and were randomized 1:1:2 to standard WBRT, SART, or DART. Within each randomized group, investigators assigned patients to two ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia has entered a five-year partnership with the ...

This project aims to bring cutting-edge molecular diagnostics to Saudi Arabia using a 23-gene panel to detect key genetic ...

The FDA is currently evaluating the application of intravesical mitomycin for low-grade intermediate-risk non–muscle-invasive bladder cancer.

A bladder ultrasound gives providers clues about how the bladder expands and holds urine. This article lists conditions ...

ALPMF's expanding lineup of cancer drugs, including zolbetuximab, positions them for substantial market growth and potential appreciation.

UroGen Pharma has reported its financial results for the third quarter of 2024, highlighting the FDA’s acceptance of its New Drug Application for UGN-102, a potential breakthrough treatment for ...

The research team has been awarded a £100,000 grant from Cancer Research UK (CRUK) to test the performance of a urine-based ...